HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ESPR
Esperion Therapeutics Inc
Healthcare Drug Manufacturers - Specialty & Generic · Michigan, USA · Reports in usd
Market Cap: $743.5M
Market Cap
$743.5M
Enterprise Val
$1.12B
P/E Ratio
-32.78
P/B Ratio
-2.46
Trailing PEG (1Y)
0.08
As Of
Apr 30, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$302.0M
Gross Margin83.46%
Profit Margin83.46%
Return on Equity5.62%
Return on Assets-6.04%
Current Ratio1.54
Debt/Equity-1.81
LT Debt/Equity-1.52
Revenue Per Share0.70

Income Statement

Dec 31, 2025
Revenue$168.4M
Cost of Revenue$27.9M
Gross Profit$140.6M
R&D$13.9M
SG&A$41.4M
Operating Expenses$55.4M
Operating Income$85.2M
Interest Expense$22.6M
Tax Expense$1.8M
Net Income$61.8M
EPS (Basic)$0.32
EPS (Diluted)$0.32
EBIT$86.3M
EBITDA$86.3M
Consolidated Income$61.8M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$167.9M
Accounts Receivable$140.2M
Inventory$105.1M
Current Assets$462.6M
LT Investments$0.00
Property, Plant & Equipment$3.3M
Intangibles$56.0K
Non-Current Assets$3.3M
Total Assets$465.9M
Accounts Payable$65.1M
Current Debt$89.7M
Current Liabilities$300.8M
LT Debt$458.3M
Non-Current Liabilities$467.0M
Total Liabilities$767.9M
Total Debt$548.0M
Retained Earnings-$1.62B
Shareholder Equity-$302.0M
Shares Outstanding239,063,437

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$45.2M
Investing Cash Flow$0.00
Financing Cash Flow$30.2M
CapEx$0.00
Free Cash Flow$45.2M
Depreciation & Amort.$26.0K
Stock-Based Comp$2.4M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$54.9M
Equity Issued/Repaid$84.8M
Dividends Paid$0.00
Net Change in Cash$75.4M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h